<DOC>
	<DOCNO>NCT00356213</DOCNO>
	<brief_summary>The laparoscopic sleeve-gastrectomy ( SG ) compare laparoscopic proximal Roux-Y-gastric bypass ( PGB ) successful treatment morbid obesity majority patient . In case insufficient weight loss malabsorption add perform laparoscopic bilious-pancreatic diversion duodenal switch ( BPD ) . The resection gastric fundus ( LG ) lead change gastrointestinal hormone possibly different bypass fundus ( PGB ) .</brief_summary>
	<brief_title>Comparison Laparoscopic Sleeve Gastrectomy Roux-Y-gastric Bypass Treatment Morbid Obesity</brief_title>
	<detailed_description>Background Obesity reach epidemic proportion develop world . In morbidly obese patient surgical treatment ( bariatric operation ) lead sustain weight loss cure comorbidities majority patient . There exist number different operation result either restrictive effect and/or malabsorption , accompany humoral effect cause change different gastrointestinal hormone . It still unknown patient needs operation . Working Hypothesis The laparoscopic sleeve-gastrectomy ( SG ) compare laparoscopic proximal Roux-Y-gastric bypass ( PGB ) successful treatment morbid obesity majority patient . In case insufficient weight loss malabsorption add perform laparoscopic bilious-pancreatic diversion duodenal switch ( BPD ) . The resection gastric fundus ( LG ) lead change gastrointestinal hormone possibly different bypass fundus ( PGB ) . Specific Aims We plan compare SG PGB prospective randomize study . Primary outcome measure effectiveness term weight loss , reduction co-morbidity quality life , secondary outcome measure early morbidity , duration cost operation , late morbidity , re-operations ( complication , insufficient weight loss ) , postoperative change gastrointestinal hormone . Experimental Design/Methods An interdisciplinary team evaluate morbidly obese patient bariatric surgery . After informed consent eligible patient randomize SG PGB , number 45 per group . Preoperative examination consist : quantification comorbidity , eat behavior , indirect calorimetry , body composition dual energy x-ray absorptiometry ( DEXA ) , routine blood chemistry , gastrointestinal hormone test meal , gastroscopy , manometry esophagus , upper GI series , abdominal ultrasound , quality life . Perioperative investigation : operative time , fat tissue sample ( omental subcutaneous ) , early morbidity , gastrointestinal hormone test meal , duration hospital stay , cost ; Follow-up data obtain every 3 month first year , twice second year per year thereafter : weight , reduction comorbidities , blood test , gastrointestinal hormone test meal , DEXA quality life .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Swiss patient approval health insurance Patients outside Switzerland : patient insurance cover cost BMI &gt; 40 contraindication bariatric surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>morbid obesity</keyword>
	<keyword>bariatric surgery</keyword>
	<keyword>sleeve-gastrectomy</keyword>
	<keyword>Roux-Y-gastric bypass</keyword>
	<keyword>outcome</keyword>
	<keyword>weight loss</keyword>
</DOC>